Article ; Online: CRESSP: a comprehensive pipeline for prediction of immunopathogenic SARS-CoV-2 epitopes using structural properties of proteins.
2022 Volume 23, Issue 2
Abstract: The development of autoimmune diseases following SARS-CoV-2 infection, including multisystem inflammatory syndrome, has been reported, and several mechanisms have been suggested, including molecular mimicry. We developed a scalable, comparative ... ...
Abstract | The development of autoimmune diseases following SARS-CoV-2 infection, including multisystem inflammatory syndrome, has been reported, and several mechanisms have been suggested, including molecular mimicry. We developed a scalable, comparative immunoinformatics pipeline called cross-reactive-epitope-search-using-structural-properties-of-proteins (CRESSP) to identify cross-reactive epitopes between a collection of SARS-CoV-2 proteomes and the human proteome using the structural properties of the proteins. Overall, by searching 4 911 245 proteins from 196 352 SARS-CoV-2 genomes, we identified 133 and 648 human proteins harboring potential cross-reactive B-cell and CD8+ T-cell epitopes, respectively. To demonstrate the robustness of our pipeline, we predicted the cross-reactive epitopes of coronavirus spike proteins, which were recognized by known cross-neutralizing antibodies. Using single-cell expression data, we identified PARP14 as a potential target of intermolecular epitope spreading between the virus and human proteins. Finally, we developed a web application (https://ahs2202.github.io/3M/) to interactively visualize our results. We also made our pipeline available as an open-source CRESSP package (https://pypi.org/project/cressp/), which can analyze any two proteomes of interest to identify potentially cross-reactive epitopes between the proteomes. Overall, our immunoinformatic resources provide a foundation for the investigation of molecular mimicry in the pathogenesis of autoimmune and chronic inflammatory diseases following COVID-19. |
---|---|
MeSH term(s) | Algorithms ; Computational Biology/methods ; Cross Reactions/immunology ; Epitopes/chemistry ; Epitopes/immunology ; Epitopes, B-Lymphocyte ; Epitopes, T-Lymphocyte ; Histocompatibility Antigens Class I/chemistry ; Histocompatibility Antigens Class I/immunology ; Histocompatibility Antigens Class II/chemistry ; Histocompatibility Antigens Class II/immunology ; Models, Molecular ; Molecular Mimicry ; Neural Networks, Computer ; Proteome ; Proteomics/methods ; SARS-CoV-2/immunology ; Software ; Structure-Activity Relationship ; Viral Proteins/chemistry ; Viral Proteins/immunology ; Web Browser |
Chemical Substances | Epitopes ; Epitopes, B-Lymphocyte ; Epitopes, T-Lymphocyte ; Histocompatibility Antigens Class I ; Histocompatibility Antigens Class II ; Proteome ; Viral Proteins |
Language | English |
Publishing date | 2022-02-28 |
Publishing country | England |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2068142-2 |
ISSN | 1477-4054 ; 1467-5463 |
ISSN (online) | 1477-4054 |
ISSN | 1467-5463 |
DOI | 10.1093/bib/bbac056 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6262: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.